Medication Reconciliation in Oncological Patients: A Randomized Clinical Trial
Author(s) -
T. González-Carrascosa Vega,
Jesús Francisco Sierra-Sánchez,
María José Martínez Bautista,
Fátima García-Martín,
Francisco Suárez-Carrascosa,
José Manuel Baena-Cañada
Publication year - 2016
Publication title -
journal of managed care and specialty pharmacy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.126
H-Index - 63
eISSN - 2376-1032
pISSN - 2376-0540
DOI - 10.18553/jmcp.2016.15248
Subject(s) - medicine , comorbidity , incidence (geometry) , randomized controlled trial , clinical endpoint , relative risk , intervention (counseling) , charlson comorbidity index , emergency medicine , physical therapy , confidence interval , psychiatry , optics , physics
Medication reconciliation is considered to be an important strategy for increasing the safety of medication use. However, few studies have been carried out showing the effect of a medication reconciliation program on the incidence of reconciliation errors (REs) in oncological patients treated in the outpatient setting.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom